Kopran Ltd.

View in App
141.45 -1.10 ▼-0.8%

26 May 2023, 04:14:29 PM
Volume: 157,538

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kopran.com
Market Cap 681.94 Cr.
Enterprise Value(EV) 744.60 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 5.65 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 25.09 Trailing Twelve Months Ending 2023-03
Industry PE 31.87 Trailing Twelve Months Ending 2023-03
Book Value / Share 91.11 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.56 Calculated using Price: 141.75
Dividend Yield 2.12 Period Ending 2022-03
No. of Shares Subscribed 4.82 Cr. 48,210,605 Shares
FaceValue 10
About Kopran Ltd.
The company was incorporated on April 26, 1958 as a private limited company under the name Kopran Chemical Company Pvt. Ltd. by Ramanlal V Shah Sevantilal, A Shah , Chimanlal G Sheth and Jivanalal M Shah. In 1972, the company's management was acquired by Chemo Pharma Laboratories Ltd and the Company's products were marketed by them.

Kopran Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Kopran Ltd. Performance

View details >>
1 Day
-0.77%
1 Week
-4.36%
1 Month
-8.45%
3 Month
+24.08%
6 Month
-16.18%
1 Year
-36.46%
2 Year
-31.62%
5 Year
+135.95%
10 Year
+921.30%

Kopran Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 17.65 -43.06 12.19 17.71 15.21 15.34 11.74 28.34 18.19
Return on Capital Employed (%) 14.27 -12.48 13.09 19.24 13.88 16.30 13.69 30.40 21.40
Return on Assets (%) 6.11 -13.63 3.98 7.15 6.77 7.27 5.84 15.22 11.62

Kopran Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 115 99 109 125 145 168 190 245 426 439
Non Curr. Liab. 67 18 33 32 31 46 40 34 33 33
Curr. Liab. 117 158 122 136 136 135 140 161 152 177
Minority Int.
Equity & Liab. 299 275 264 293 312 349 370 439 611 650
Non Curr. Assets 139 105 110 114 118 142 148 162 196 251
Curr. Assets 160 170 154 180 194 208 223 277 415 399
Misc. Exp. not W/O
Total Assets 299 275 264 293 312 349 370 439 611 650

Kopran Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 303 326 296 310 313 358 360 492 478 549
Other Income 2 7 2 11 11 4 1 18 11 7
Total Income 305 332 299 320 324 362 360 510 488 557
Total Expenditure -260 -294 -266 -274 -284 -312 -313 -410 -390 -502
PBIDT 45 38 33 47 40 49 47 100 98 55
Interest -14 -13 -13 -14 -9 -9 -9 -6 -5 -6
Depreciation -13 -10 -8 -8 -9 -9 -10 -10 -11 -13
Taxation -5 -2 -8 -7 -22 -21 -9
Exceptional Items -54 -1 -1
PAT 17 -39 11 20 20 24 21 62 61 27
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 17 -39 11 20 20 24 21 62 61 27
Adjusted EPS 4 -10 2 5 5 6 5 14 13 6

Kopran Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 15 3 46 29 16 26 25 31 60 -33
Cash Fr. Inv. -9 -9 -10 -9 -18 -11 -25 -13 -25 -84
Cash Fr. Finan. -12 7 -37 -19 2 -15 -1 -18 -35 123
Net Change -7 0 0 0 0 0 0 0 0 5
Cash & Cash Eqvt 1 1 1 1 1 0 0 1 1 6

Kopran Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 43.78 43.78 43.78 43.78 44.25 44.25 44.25 44.30 44.30
Public 56.22 56.22 56.22 56.22 55.75 55.75 55.75 55.70 55.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kopran Ltd. Announcements

View details >>
Fri, 26 May 2023
Copy of Newspaper Publication
Kopran Limited has informed the Exchange about Copy of Newspaper Publication
Fri, 26 May 2023
Dividend
Kopran Limited has informed the Exchange that Board of Directors at its meeting held on May 25, 2023, recommended Final Dividend of 3.00 per equity share.
Fri, 26 May 2023
Loss of Share Certificates
Kopran Limited has informed the Exchange about Loss of Share Certificates

Kopran Ltd. Technical Scans

View details >>
Fri, 26 May 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Below Last Week Low Close Below Last Week Low
High Decrease in 1 Month High Decrease in 1 Month

Kopran Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Kopran Ltd. FAQ's

What is Kopran share price?
Can I buy Kopran shares now?
What is the Dividend Yield of Kopran?
What is the Market Cap of Kopran?
What are the key metrics to analyse Kopran?
What is the 52 Week High and Low of Kopran?
What is the trend of Kopran share price?